A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

A retired HGV driver was the first person in the world to take part in a clinical trial to extend the lifespan of blood ...

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

U.K. biotech Ikarovec has teamed up with VectorBuilder to work on an eye disease gene therapy that could be administered in a ...

By Karen Roman Biopharmaceutical company Medera Inc. said it completed patient enrollment for Cohort B of its clinical trial ...

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...

Expected rapid advances in CAR T and other cellular therapies may expand treatment options not only in cancer but also in ...

The American Society of Gene & Cell Therapy (ASGCT), the leading professional organization for the advancement of cell and gene therapies (CGTs), and the Orphan Therapeutics Accelerator (OTXL), a ...

The global cell and gene therapy third-party logistics market size was valued at USD 1.81 billion in 2025 and is predicted to ...

This story is part of a series on the current progression in Regenerative Medicine. In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged ...

A five-year-old boy who received the world's most expensive drug as a baby has made "incredible progress" and can walk ...